{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:57:44Z","timestamp":1793113064200,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ygyno.2021.05.014","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T01:57:38Z","timestamp":1622253458000},"page":"322-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China"],"prefix":"10.1016","volume":"162","author":[{"given":"Fangbin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Belinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisha","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.05.014_bb0005","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.30090","article-title":"The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples","volume":"139","author":"Ebisch","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamaoncol.2020.6575","article-title":"Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial","volume":"7","author":"Zhang","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234518","article-title":"The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples","volume":"15","author":"Song","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0045","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0050","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the PAP smear?","volume":"50","author":"Wright","year":"2007","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0060","first-page":"147","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer a retrospective cross-sectional worldwide study","volume":"11","author":"Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0070","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1001\/jamainternmed.2019.0306","article-title":"Clinical evaluation of human papillomavirus screening with p16\/Ki-67 dual stain triage in a large organized cervical cancer screening program","volume":"179","author":"Wentzensen","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15781","article-title":"Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus-based screening in Mexico","volume":"2","author":"Torres-Ibarra","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"2020","key":"10.1016\/j.ygyno.2021.05.014_bb0080","first-page":"102","article-title":"ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2019","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.05.014_bb0085","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0090","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jiph.2020.08.008","article-title":"Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort","volume":"13","author":"Song","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0095","article-title":"The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening","author":"Song","year":"2020","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0100","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1055-9965.EPI-19-0239","article-title":"Role of HPV genotype, multiple infections and viral load on the risk of high-grade cervical neoplasia","volume":"28","author":"Adcock","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.32291","article-title":"Bayesian analysis of baseline risk of CIN2 and >\/=CIN3 by HPV genotype in a European referral cohort","volume":"145","author":"Bonde","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ijgc-00009577-200601000-00056","article-title":"Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia","volume":"16","author":"Ishikawa","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2014.01.006","article-title":"The development and evaluation of a community based model for cervical cancer screening based on self-sampling","volume":"132","author":"Belinson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/LGT.0000000000000577","article-title":"Evaluation of cobas HPV and SeqHPV assays in the chinese multicenter screening trial","volume":"25","author":"Du","year":"2021","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12879-021-06109-4","article-title":"Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China","volume":"21","author":"Song","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000381842","article-title":"The Pap Test and Bethesda 2014. \u201cThe reports of my demise have been greatly exaggerated.\u201d (after a quotation from Mark Twain)","volume":"59","author":"Nayar","year":"2015","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0140","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/LGT.0000000000000239","article-title":"A standard protocol for the colposcopy exam","volume":"20","author":"Belinson","year":"2016","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0145","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.32973","article-title":"Combined use of cytology, P16 immunostaining and genotyping for triage of women positive for high risk human papillomavirus at primary screening","volume":"147","author":"Cuzick","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.014_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Athena HPV Study Group. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1940-6207.CAPR-19-0144","article-title":"Performance of HPV genotyping combined with p16\/Ki-67 in detection of cervical precancer and cancer among HPV-positive chinese women","volume":"13","author":"Jiang","year":"2019","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0160","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/ijc.32669","article-title":"Approaches to triage optimization in HPV primary screening: Extended genotyping and p16\/Ki-67 dual-stained cytology - retrospective insights from ATHENA","volume":"146","author":"Stoler","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41416-020-0850-6","article-title":"Impact of HPV vaccination on cervical screening performance: a population-based cohort study","volume":"123","author":"Lei","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.014_bb0170","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.2147\/CMAR.S273079","article-title":"Evaluating the performance of p16INK4a immunocytochemistry in cervical cancer screening","volume":"12","author":"Song","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/cncy.22428","article-title":"Clinical evaluation of p16 immunocytology in cervical cancer screening: a population-based cross-sectional study from rural China","author":"Rezhake","year":"2021","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0180","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0190","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/modpathol.2017.16","article-title":"Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women","volume":"30","author":"Ebisch","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2021.05.014_bb0195","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-19-1180","article-title":"Evaluation of p16\/Ki-67 dual-stained cytology in triaging HPV-positive women during cervical cancer screening","volume":"29","author":"Hu","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:35Z","timestamp":1758772595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821004108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0090825821004108"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}